Montai Therapeutics
Focus: Montai Therapeutics is an AI-driven small molecule platform company focused on immunology and gastroenterology indications. The company operates as a pre-revenue biotech with a lean footprint in Cambridge, MA.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
3
Should You Work at Montai Therapeutics?
AI assessmentMontai is a high-risk, high-optionality play suitable only for founders-minded scientists willing to tolerate uncertainty in exchange for early-stage equity upside and technology building.
Why Work Here
- Opportunity to build from ground level at an AI-focused platform company with differentiated technology in high-value therapeutic areas (immunology, GI) — early-stage equity potential
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Montai Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.